4//SEC Filing
INSPIRE PHARMACEUTICALS INC 4
Accession 0001181431-11-030078
CIK 0001040416operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:07 PM ET
Size
63.4 KB
Accession
0001181431-11-030078
Insider Transaction Report
Form 4
STAAB THOMAS R II
CFO & Treasurer
Transactions
- Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,250→ 0 totalExercise: $3.78Exp: 2015-11-03→ Common Stock (13,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−11,250→ 0 totalExercise: $3.49Exp: 2015-05-14→ Common Stock (11,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−10,250→ 0 totalExercise: $6.49Exp: 2014-03-20→ Common Stock (10,250 underlying) - Disposition from Tender
Common Stock
2011-05-13$5.00/sh−2,000$10,000→ 20,000 total - Disposition to Issuer
Common Stock
2011-05-13$5.00/sh−20,000$100,000→ 0 total - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−22,000→ 0 totalExercise: $6.50Exp: 2017-05-11→ Common Stock (22,000 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,250→ 0 totalExercise: $3.79Exp: 2016-03-17→ Common Stock (13,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,250→ 0 totalExercise: $4.44Exp: 2015-08-13→ Common Stock (13,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−10,250→ 0 totalExercise: $5.81Exp: 2014-08-14→ Common Stock (10,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−20,500→ 0 totalExercise: $5.00Exp: 2013-08-29→ Common Stock (20,500 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−22,000→ 0 totalExercise: $6.08Exp: 2017-03-17→ Common Stock (22,000 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,250→ 0 totalExercise: $5.10Exp: 2016-11-10→ Common Stock (13,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,250→ 0 totalExercise: $3.84Exp: 2016-05-13→ Common Stock (13,250 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-05-13−10,000→ 0 totalExercise: $20.30Exp: 2013-10-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Restricted Stock Unit
2011-05-13−3,000→ 0 total→ Common Stock (3,000 underlying) - Disposition to Issuer
Restricted Stock Unit
2011-05-13−3,000→ 0 total→ Common Stock (3,000 underlying) - Disposition to Issuer
Restricted Stock Unit
2011-05-13−2,200→ 0 total→ Common Stock (2,200 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−30,000→ 0 totalExercise: $4.80Exp: 2017-08-10→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−30,000→ 0 totalExercise: $7.07Exp: 2017-11-09→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,250→ 0 totalExercise: $4.55Exp: 2016-08-10→ Common Stock (13,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−10,250→ 0 totalExercise: $6.10Exp: 2014-11-12→ Common Stock (10,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−13,000→ 0 totalExercise: $5.25Exp: 2013-01-18→ Common Stock (13,000 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−9,300→ 0 totalExercise: $15.65Exp: 2014-09-28→ Common Stock (9,300 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−8,000→ 0 totalExercise: $12.80Exp: 2014-03-15→ Common Stock (8,000 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−11,250→ 0 totalExercise: $3.98Exp: 2015-03-19→ Common Stock (11,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−10,250→ 0 totalExercise: $6.35Exp: 2014-05-14→ Common Stock (10,250 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−28,500→ 0 totalExercise: $9.42Exp: 2012-07-12→ Common Stock (28,500 underlying) - Disposition to Issuer
Stock Option (Right to buy)
2011-05-13−50,000→ 0 totalExercise: $14.71Exp: 2013-05-05→ Common Stock (50,000 underlying) - Disposition to Issuer
Restricted Stock Unit
2011-05-13−29,046→ 0 total→ Common Stock (29,046 underlying) - Disposition to Issuer
Restricted Stock Unit
2011-05-13−2,200→ 0 total→ Common Stock (2,200 underlying)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2011, by and among, Merck & Co., Inc., Monarch Transaction Corp. and Inspire Pharmaceuticals, Inc. (the "Merger Agreement"), these restricted stock units ("RSUs"), whether or not vested, were fully vested immediately prior to and cancelled immediately following the acceptance time under the Merger Agreement in exchange for the right to receive cash payment for each such RSU of $5.00, net to the seller in cash, without interest and less any required withholding taxes.
- [F2]These stock options were cancelled in accordance with the Merger Agreement. As the exercise price of the options was at or above $5.00, no cash payment was provided.
- [F3]These stock options were cancelled in accordance with the Merger Agreement in exchange for the right to receive cash payment in accordance with the Merger Agreement. The cash payment for each such option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess of $5.00 over the exercise price per share for each such option, without interest subject to any required withholding of taxes and the exercise price of such option.
Documents
Issuer
INSPIRE PHARMACEUTICALS INC
CIK 0001040416
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001040416
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:07 PM ET
- Size
- 63.4 KB